Related Experiment Video
Updated: Apr 11, 2026
11:27
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
9.6K
Crystallization of interleukin-18 for structure-based inhibitor design
Brian Krumm1, Xiangzhi Meng2, Yan Xiang2
1Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078, USA.
Summary
Researchers improved protein crystallization for Interleukin-18 (IL-18), a key immune cytokine. This advance enables structure-based drug design targeting IL-18 and its interactions.
Area of Science:
- Immunology and Structural Biology
Background:
- Interleukin-18 (IL-18) is a pro-inflammatory cytokine crucial for immune defense.
- IL-18's activity is regulated by IL-18 binding protein (IL-18BP).
- The binding interface of human IL-18 (hIL-18) is a potential drug target.
Purpose of the Study:
- To facilitate the crystallization of apo hIL-18 or hIL-18 complexes.
- To enable structure-based drug design for IL-18 therapeutics.
- To achieve crystallization under low ionic strength conditions.
Main Methods:
- Employed surface-entropy reduction (SER) technique.
- Utilized rational protein design strategies.
- Focused on obtaining crystals of hIL-18.
Main Results:
- Successfully facilitated the crystallization of hIL-18.
- Developed an effective platform for structure-based drug design.
- Demonstrated the utility of SER and rational design for challenging proteins.
Conclusions:
- The study provides a robust method for crystallizing hIL-18.
- This facilitates further structure-based drug discovery targeting IL-18.
- The developed platform is valuable for designing novel therapeutics.
